ExLibris header image
SFX Logo
Title: Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure
Source:

Acs Medicinal Chemistry Letters [1948-5875] Tang, Haifeng yr:2016


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Walsh, Shawn P. "Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation." ACS medicinal chemistry letters 6.7 (2015): 4294967295-752. Link to Full Text for this item Link to SFX for this item
2. "The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartters Syndrome Type II Phenotype." The journal of pharmacology and experimental therapeutics. 359.1: 194-206. Link to SFX for this item
3. Iwaz, James A. "New Targets in the Drug Treatment of Heart Failure." Drugs 76.2 (2015): 187-201. Link to SFX for this item
4. Eladari, D. "Electroneutral absorption of NaCl by the aldosterone-sensitive distal nephron: implication for normal electrolytes homeostasis and blood pressure regulation." Cellular and molecular life sciences 71.15 (2014): 2879-2895. Link to Full Text for this item Link to SFX for this item
5. Thomopoulos, C. "Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials." Journal of hypertension 32.12 (2014): 2296-304. Link to SFX for this item
6. Pitt, B. "Spironolactone for heart failure with preserved ejection fraction." The New England journal of medicine 370.15 (2014): 1383-1392. Link to SFX for this item
7. Sammons, Matthew F. "Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors." ACS medicinal chemistry letters 9.2 (2018): 125-130. Link to Full Text for this item Link to SFX for this item
8. Rossi, Gian P. "The molecular basis of primary aldosteronism: from chimeric gene to channelopathy." Current opinion in pharmacology 21C (2014): 35-42. Link to SFX for this item
9. Uyanik, M. "Comparison of blood gas, electrolyte and metabolite results measured with two different blood gas analyzers and a core laboratory analyzer." Scandinavian journal of clinical & laboratory investigation 75.2 (2014): 1-9. Link to SFX for this item
10. Zile, Michael R. "Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)." European journal of heart failure 16.7 (2014): 817-825. Link to Full Text for this item Link to SFX for this item
11. Benarroch, E. "Acid-sensing cation channels: Structure, function, and pathophysiologic implications." Neurology 82.7 (2014): 628-635. Link to SFX for this item
12. Perry, G. "The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure." New England Journal of Medicine, The 336.8 (1997): 525-533. Link to SFX for this item
13. Lisman, J. "Long-term potentiation: outstanding questions and attempted synthesis." Philosophical transactions of the Royal Society of London. Series B, Biological sciences 358.1432: 829-842. Link to SFX for this item
14. Landau, D. "Potassium-related inherited tubulopathies." Cellular and molecular life sciences 63.17 (2006): 1962-8. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced